Nanoarchitectonics: Complexes and Conjugates of Platinum Drugs with Silicon Containing Nanocarriers. An Overview
The development in the area of novel anticancer prodrugs (conjugates and complexes) has attracted growing attention from many research groups. The dangerous side effects of currently used anticancer drugs, including cisplatin and other platinum based drugs, as well their systemic toxicity is a drivi...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/17/9264 |
_version_ | 1797521378233024512 |
---|---|
author | Kinga Piorecka Jan Kurjata Wlodzimierz A. Stanczyk |
author_facet | Kinga Piorecka Jan Kurjata Wlodzimierz A. Stanczyk |
author_sort | Kinga Piorecka |
collection | DOAJ |
description | The development in the area of novel anticancer prodrugs (conjugates and complexes) has attracted growing attention from many research groups. The dangerous side effects of currently used anticancer drugs, including cisplatin and other platinum based drugs, as well their systemic toxicity is a driving force for intensive search and presents a safer way in delivery platform of active molecules. Silicon based nanocarriers play an important role in achieving the goal of synthesis of the more effective prodrugs. It is worth to underline that silicon based platform including silica and silsesquioxane nanocarriers offers higher stability, biocompatibility of such the materials and pro-longed release of active platinum drugs. Silicon nanomaterials themselves are well-known for improving drug delivery, being themselves non-toxic, and versatile, and tailored surface chemistry. This review summarizes the current state-of-the-art within constructs of silicon-containing nano-carriers conjugated and complexed with platinum based drugs. Contrary to a number of other reviews, it stresses the role of nano-chemistry as a primary tool in the development of novel prodrugs. |
first_indexed | 2024-03-10T08:11:45Z |
format | Article |
id | doaj.art-82bbbb600c4c40c78b559ed0839efcee |
institution | Directory Open Access Journal |
issn | 1661-6596 1422-0067 |
language | English |
last_indexed | 2024-03-10T08:11:45Z |
publishDate | 2021-08-01 |
publisher | MDPI AG |
record_format | Article |
series | International Journal of Molecular Sciences |
spelling | doaj.art-82bbbb600c4c40c78b559ed0839efcee2023-11-22T10:40:40ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-08-012217926410.3390/ijms22179264Nanoarchitectonics: Complexes and Conjugates of Platinum Drugs with Silicon Containing Nanocarriers. An OverviewKinga Piorecka0Jan Kurjata1Wlodzimierz A. Stanczyk2Centre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza 112, 90-363 Lodz, PolandCentre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza 112, 90-363 Lodz, PolandCentre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza 112, 90-363 Lodz, PolandThe development in the area of novel anticancer prodrugs (conjugates and complexes) has attracted growing attention from many research groups. The dangerous side effects of currently used anticancer drugs, including cisplatin and other platinum based drugs, as well their systemic toxicity is a driving force for intensive search and presents a safer way in delivery platform of active molecules. Silicon based nanocarriers play an important role in achieving the goal of synthesis of the more effective prodrugs. It is worth to underline that silicon based platform including silica and silsesquioxane nanocarriers offers higher stability, biocompatibility of such the materials and pro-longed release of active platinum drugs. Silicon nanomaterials themselves are well-known for improving drug delivery, being themselves non-toxic, and versatile, and tailored surface chemistry. This review summarizes the current state-of-the-art within constructs of silicon-containing nano-carriers conjugated and complexed with platinum based drugs. Contrary to a number of other reviews, it stresses the role of nano-chemistry as a primary tool in the development of novel prodrugs.https://www.mdpi.com/1422-0067/22/17/9264anticancer platinum drugsnanoconjugatesnanocomplexes synthesis and propertiessilicon containing nanocarriers |
spellingShingle | Kinga Piorecka Jan Kurjata Wlodzimierz A. Stanczyk Nanoarchitectonics: Complexes and Conjugates of Platinum Drugs with Silicon Containing Nanocarriers. An Overview International Journal of Molecular Sciences anticancer platinum drugs nanoconjugates nanocomplexes synthesis and properties silicon containing nanocarriers |
title | Nanoarchitectonics: Complexes and Conjugates of Platinum Drugs with Silicon Containing Nanocarriers. An Overview |
title_full | Nanoarchitectonics: Complexes and Conjugates of Platinum Drugs with Silicon Containing Nanocarriers. An Overview |
title_fullStr | Nanoarchitectonics: Complexes and Conjugates of Platinum Drugs with Silicon Containing Nanocarriers. An Overview |
title_full_unstemmed | Nanoarchitectonics: Complexes and Conjugates of Platinum Drugs with Silicon Containing Nanocarriers. An Overview |
title_short | Nanoarchitectonics: Complexes and Conjugates of Platinum Drugs with Silicon Containing Nanocarriers. An Overview |
title_sort | nanoarchitectonics complexes and conjugates of platinum drugs with silicon containing nanocarriers an overview |
topic | anticancer platinum drugs nanoconjugates nanocomplexes synthesis and properties silicon containing nanocarriers |
url | https://www.mdpi.com/1422-0067/22/17/9264 |
work_keys_str_mv | AT kingapiorecka nanoarchitectonicscomplexesandconjugatesofplatinumdrugswithsiliconcontainingnanocarriersanoverview AT jankurjata nanoarchitectonicscomplexesandconjugatesofplatinumdrugswithsiliconcontainingnanocarriersanoverview AT wlodzimierzastanczyk nanoarchitectonicscomplexesandconjugatesofplatinumdrugswithsiliconcontainingnanocarriersanoverview |